• 한국의학물리학회지:의학물리
• /
• 제28권4호
• /
• pp.207-217
• /
• 2017

For effective patient treatment in proton therapy, it is therefore important to accurately measure the beam range. For measuring beam range, various researchers determine the beam range by measuring the prompt gammas generated during nuclear reactions of protons with materials. However, the accuracy of the beam range determination can be lowered in heterogeneous phantoms, because of the differences with respect to the prompt gamma production depending on the properties of the material. In this research, to improve the beam range determination in a heterogeneous phantom, we derived a formula to correct the prompt-gamma distribution using the ratio of the prompt gamma production, stopping power, and density obtained for each material. Then, the prompt-gamma distributions were acquired by a multi-slit prompt-gamma camera on various kinds of heterogeneous phantoms using a Geant4 Monte Carlo simulation, and the deduced formula was applied to the prompt-gamma distributions. For the case involving the phantom having bone-equivalent material in the soft tissue-equivalent material, it was confirmed that compared to the actual range, the determined ranges were relatively accurate both before and after correction. In the case of a phantom having the lung-equivalent material in the soft tissue-equivalent material, although the maximum error before correction was 18.7 mm, the difference was very large. However, when the correction method was applied, the accuracy was significantly improved by a maximum error of 4.1 mm. Moreover, for a phantom that was constructed based on CT data, after applying the calibration method, the beam range could be generally determined within an error of 2.5 mm. Simulation results confirmed the potential to determine the beam range with high accuracy in heterogeneous phantoms by applying the proposed correction method. In future, these methods will be verified by performing experiments using a therapeutic proton beam.

• Radiation Oncology Journal
• /
• 제36권3호
• /
• pp.182-191
• /
• 2018

Purpose: To investigate the clinical outcome of proton therapy (PT) in patients with chordoma. Materials and Methods: Fifty-eight patients with chordoma treated with PT between June 2007 and December 2015 at the National Cancer Center, Korea, were retrospectively analyzed. The median total dose was 69.6 cobalt gray equivalent (CGE; range, 64.8 to 79.2 CGE). Local progression-free survival (LPFS), distant metastasis-free survival (DMFS), overall survival (OS), and disease-specific survival (DSS) rates were calculated by the Kaplan-Meier method. Results: With the median follow-up of 42.8 months (range, 4 to 174 months), the 5-year LPFS, DMFS, OS, and DSS rates were 87.9%, 86.7%, 88.3%, and 92.9%, respectively. The tumor location was associated with the patterns of failure: the LPFS rates were lower for cervical tumors (57.1%) than for non-cervical tumors (93.1%) (p = 0.02), and the DMFS rates were lower for sacral tumors (53.5%) than for non-sacral tumors (100%) (p = 0.001). The total dose was associated with both the LPFS rate and DMFS rate. The initial tumor size was associated with the DMFS rate, but was not associated with the LPFS rate. Three patients had grade 3 late toxicity with none ≥grade 4. Conclusion: PT is an effective and safe treatment in patients with chordomas. The tumor location was associated with the patterns of failure: local failure was common in cervical tumors, and distant failure was common in sacral tumors. Further refinement of PT, such as the utilization of intensity modulated PT for cervical tumors, is warranted to improve the outcome.

• 한국진공학회지
• /
• 제13권1호
• /
• pp.1-8
• /
• 2004

양성자 주입과 웨이퍼접합기술을 접목한 ion-cut기술로서 SOI 웨이퍼를 제조하는 기술을 개발하고자 하였다. TRIM 전산모사결과 표준 SOI 웨이퍼 (200 nm SOI, 400 nm BOX) 제조를 위해서는 65 keV의 양성자주입이 요구됨을 알 수 있었다. 웨이퍼분리를 위한 최적 공정조건을 얻기 위해 조사선량과 열처리조건(온도 및 시간)에 따른 표면변화를 조사하였다. 실험결과 유효선량범위는 6∼$9\times10^{16}$ $H^{+}/\textrm{cm}^2$이며, 최적 아닐링조건은 $550^{\circ}C$에서 30분 정도로 나타났다. 주입된 수소의 깊이분포는 ERD(Elastic Recoil Detection)와 SIMS(Secondary Ion Mass Spectrometry)측정에 의해 실험적으로 확인되었다. 아울러 상해층의 미세구조 형성기구를 X-TEM측정을 통해 조사하였다.

• 대한방사선치료학회지
• /
• 제25권1호
• /
• pp.25-31
• /
• 2013

목 적: 양성자선의 유효비정 변화와 환자 자세의 재현성을 고려한 로버스트(robust-IMPT) 세기조절양성치료와 플레인 세기조절양성자치료(plain-IMPT) 계획과 광자선 세기조절방사선치료(photon-IMRT, step & shoot) 계획의 선량분포 특성을 비교, 분석하고자 한다. 대상 및 방법: 다섯 명의 전립선암 환자를 대상으로 표적에 70 Gy를 조사하도록 photon-IMRT (7문, step & shoot)와 plain-IMPT (2문, 4문, 7문) 및 robust-IMPT (유효 비정 오차 ${\pm}5%$ & 환자 자세 오차 0.5 cm 적용) 치료계획을 수립했다. 세 가지 치료계획으로 얻은 선량 분포 비교를 위해 PTV에 대한 선량조형지수(Conformity Index, CI), 선량균등지수(Homogeneity Index, HI) 및 최대선량, 최소선량, 평균선량과 OAR에 대한 선량-체적을 평가했다. 결 과: 모든 환자에 대해 photon-IMRT, plain-IMPT, robust-IMPT에서 PTV의 평균 최대선량은 각각 76.75 Gy (109.6%), 71.92 Gy (102.7%), 72.09 Gy (103%)였으며, 평균 최소선량은 68.21 Gy (97.4%), 68.89 Gy (98.42%), 68.13 Gy (98.13%)였으며, 전체 평균선량은 각각 71.02 Gy (101.4%), 71.32 Gy (100.4%), 70.75 Gy (101%)였다. PTV에 대한 CI 및 HI 값은 plain-IMPT가 photon-IMRT와 robust-IMPT에 비하여 1.02, 1.00으로 가장 낮았다. 또한, 정상장기에 있어 plain-IMPT가 photon-IMRT에 비하여 대부분 낮은 선량 분포를 보였으며, robust-IMPT 적용 시 정상 장기에 대한 선량 분포가 다소 변동의 폭은 있었지만 photon-IMRT에 비하여 대체로 낮은 선량 분포를 보였다. 결 론: 전립선암의 IMPT 치료 시 정확한 유효비정의 오차와 환자 자세 재현성오차를 고려한 robust-IMPT를 적용한다면 plain-IMPT의 선량학적 불확도를 줄이고 photon-IMRT에 비해 효과적인 치료를 제공할 수 있을 것이다.

• 한국의학물리학회지:의학물리
• /
• 제23권3호
• /
• pp.162-168
• /
• 2012

양성자 치료에서 치료의 목표를 달성하고 환자의 안전을 제고하기 위해 인체 내 양성자 빔의 분포를 확인하는 것이 중요하다. 양성자 선량분포와 밀접한 관계가 있는 즉발감마선의 2차원 분포 측정을 위하여 본 연구팀에서는 다수의 CsI(Tl) 섬광체가 1차원 종형으로 배열된 검출기 배열과 집속장치 및 다채널 신호처리 장치로 이루어진 측정장치를 개발하고 있다. 이에 본 연구에서 몬테칼로 기반의 MCNPX 코드를 이용하여 최적화된 측정 장치를 설계하고자 하였다. 즉발감마선을 효과적으로 측정하기 위해 CsI(Tl) 섬광체의 크기를 $6{\times}6{\times}50mm^3$로 결정하였으며, 배경감마선의 영향을 최소화하고 빔의 진행방향에서 수직방향으로 발생하는 즉발감마선만 측정하기 위해 집속장치의 구멍 크기는 면적 $6{\times}6mm^2$, 길이 150 mm로 최적화되었다. 150 MeV 양성자 빔에 대한 성능 예측 전산모사연구를 수행한 결과, 본 연구에서 최적화된 측정 장치를 통해 즉발감마선 2차원 분포를 측정할 수 있었으며, 1 mm 오차범위에서 양성자 빔의 비정을 결정할 수 있었다. 이를 바탕으로 현재 다채널의 신호처리 장치를 개발하고 있으며 실제 양성자 빔을 이용한 즉발감마선 분포측정을 통해 측정 장치의 성능을 검증할 것이다.

• Nuclear Engineering and Technology
• /
• 제53권3호
• /
• pp.949-959
• /
• 2021

The current study aims to explore the shielding properties of multi-component borate-based glass series. Seven glass-samples with composition of (80-y)H₃BO₃-10ZnO-10Na₂O-yBaO where (y = 0, 5, 10, 15, 20, 25 and 30 mol.%) were synthesized by melt-quench method. Various shielding features for photons, neutrons, and protons were determined for all prepared samples. XCOM, Phy-X program, and SRIM code were performed to determine and explain several shielding properties such as equivalent atomic number, exposure build-up factor, specific gamma-ray constants, effective removal cross-section (Σ_R), neutron scattering and absorption, Mass Stopping Power (MSP) and projected range. The energy ranges for photons and protons were 0.015-15 MeV and 0.01-10 MeV, respectively. The mass attenuation coefficient (μ/ρ) was also determined experimentally by utilizing two radioactive sources (¹⁶⁶Ho and ¹³⁷Cs). Consistent results were obtained between experimental and XCOM values in determining μ/ρ of the new glasses. The addition of BaO to the glass matrix led to enhance the μ/ρ and specific gamma-ray constants of glasses. Whereas the remarkable reductions in Σ_R, MSP, and projected range values were reported with increasing BaO concentrations. The acquired results nominate the use of these glasses in different radiation shielding purposes.

• 천문학논총
• /
• 제21권2호
• /
• pp.87-94
• /
• 2006

The COREA (COsmic ray Research and Education Array in Korea) project aims to build a ground array of particle detectors distributed over Korean Peninsular, through collaborations of high school students, educators, and university researchers, in order to study the origin of ultra high energy cosmic rays. COREA array will consist of about 2000 detector stations covering several hundreds of $km^2$ area at its final configuration and detect electrons and muons in extensive air-showers triggered by high energy particles. During the intial phase COREA array will start with a small number of detector stations in Seoul area schools. In this paper, we have studied by Monte Carlo simulations how to select detector sites for optimal detection efficiency for proton triggered air-showers. We considered several model clusters with up to 30 detector stations and calculated the effective number of air-shower events that can be detected per year for each cluster. The greatest detection efficiency is achieved when the mean distance between detector stations of a cluster is comparable to the effective radius of the air-shower of a given proton energy. We find the detection efficiency of a cluster with randomly selected detector sites is comparable to that of clusters with uniform detector spacing. We also considered a hybrid cluster with 60 detector stations that combines a small cluster with ${\Delta}{\iota}{\approx}100m$ and a large cluster with ${Delta}{\iota}{\approx}1km$. We suggest that it can be an ideal configuration for the initial phase study of the COREA project, since it can measure the cosmic rays with a wide range energy, i.e., $10^{16}eV{\leq}E{\leq}10^{19}eV$, with a reasonable detection rate.

• 한국진공학회지
• /
• 제14권2호
• /
• pp.91-96
• /
• 2005

양성자 주입과 웨이퍼접합기술을 접목한 ion-cut기술로서 SOI 웨이퍼를 제조하는 기술을 개발하였다. SRIM 전산모사에 의하면 일반 SOI 웨이퍼 (200nm SOI, 400nm BOX) 제조에는 65keV의 양성자주입이 요구된다. 웨이퍼분리를 위한 최적 공정조건을 얻기 위해 조사선량과 열처리조건(온도 및 시간)에 따른 blistering 및 flaking 등의 표면변화를 조사하였다. 실험결과 유효선량범위는 $6\~9times10^{16}H^+/cm^2$이며, 최적 아닐링조건은 $550^{\circ}C$에서 30분 정도로 나타났다. RCA 세정법으로서 친수성표면을 형성하여 웨이퍼 직접접합을 수행하였으며, IR 조사에 의해 무결함접합을 확인하였다 웨이퍼 분리는 예비실험에서 정해진 최적조건에서 이루어졌으며, SOI층의 안정화를 위해 고온열처리($1,100^{\circ}C,\;60$분)를 시행하였다. TEM 측정상 SOI 구조결함은 발견되지 않았으며, BOX(buried oxide)층 상부계면상의 포획전하밀도는 열산화막 계면의 낮은 밀도를 유지함을 확인하였다.

• 대한기관식도과학회지
• /
• 제9권1호
• /
• pp.60-66
• /
• 2003

Although there is a wide range of diseases caused by gastric acid reflux and the number of cases is on the rise, it is difficult for the laryngologist to make the correct diagnosis. The treatment for laryngopharyngeal reflux can be grouped into 3 categories - changes in lifestyle, medication, and surgery. The medication used to treat laryngopharyngeal reflux are prokinetic agents and acid supressive agents such as antacids, H2 blockers, and PPIs(Proton pump inhibitor). Rabeprazole sodium($Pariet^{\circledR}$) is a newly developed agent belonging to the PPI group, but in contrast with the existing drugs such as omeprazole, lansoprazole, pantoprazole, has a low dependency on CYP2C19 during the metabolic cycle. Thus, it is known to have a quick but fixed antiacid effect and less individual differences. We analyzed 2166 patients from 32 hospitals who were prescribed $Pariet^{\circledR}$ from May, 2001 to April, 2002. The patients were divided into 4 groups according to the duration of treatment - Group 1: 1-14 days, Group 2: 15-28 days, group 3: 29-56 days, Group 4: more than 56 days. The cases were then analyzed for improvement of 8 symptoms(heart bum, regurgitation, chronic cough, hoarseness, globus sensation, chronic throat clearing, sore throat, and dysphagia), improvement on laryngoscope, usefulness to the doctor, and complication development. Of the total of 2116 patients, 1627(75.1%) cases showed at least 50% improvement of symptoms and the amount of improvement increased according to the duration of medical treatment. Most of the patients showed objective improvement on the laryngoscope, with 32.9% showing significant improvement and 38.7% showing moderate improvement. 37.6% of the doctors questioned replied that $Pariet^{\circledR}$ was very useful and 50.3% said it was useful, showing that most were satisfied with the treatment results. The complications known to develop after taking PPI are headache, nausea, diarrhea, abdominal pain, constipation, dizziness, fatigue, and of these, only a small percentage of the patients complained of mild headache. $Pariet^{\circledR}$ has shown to be a relatively safe and effective drug for the treatment of laryngopharyngeal reflux.

• 대한후두음성언어의학회지
• /
• 제18권2호
• /
• pp.108-112
• /
• 2007

Otolaryngological manifestations of acid reflux include a wide range of pharyngeal and laryngeal symptoms ; and the constellation of symptoms has been called laryngopharyngeal reflux (LPR). In the absence of definite diagnostic criteria, LPR disease remains a subjective entity. A diagnosis of LPR is usually based on response of symptoms to empirical treatment. Investigative modalities such as pH monitoring and, more recently, impedance studies are generally reserved for treatment failures. LPR usually requires more aggressive and prolonged treatment to achieve regression of both symptoms and laryngeal findings. The suppression of gastric acid and secretion with anti-secretary agents has been the mainstay of medical treatment for patients with acid-related disorders. The suppression of gastric acid secretion achieved with Hz-receptor antagonist $(H_2RA)$ has proved suboptimal for relief of reflux symptoms. The rapid development of tolerance and rebound acid hypersecretion after the with-drawal of $H_2RA$ limit their clinical use. Proton pump inhibitors (PPI) have been proved to be very effective for suppressing intragastric acidity, but the optimal dose and duration is unknown. Current evidence indicates that pharmacologic intervention should include, at a minimum, a 3 month trial of twice daily PPI. Symptoms of LPR improve over 2 months of therapy. The physical findings of LPR resolve more slowly than the symptoms and this continues through out at least 6 months of treatment. For most patients with LPR, twice daily dosing with a PPI is usually recommended for an initial treatment for a period of no less than 6 months treatment, and lifetime treatment may be required.